Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
Bunta Yoshimura,1,2 Tomoya Hirota,3 Manabu Takaki,2 Yoshiki Kishi,11Department of Psychiatry, Okayama Psychiatric Medical Center, 2Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; 3Department of Psychiatry, Vanderbi...
Guardado en:
Autores principales: | Yoshimura B, Hirota T, Takaki M, Kishi Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93eaf39f52ff4b6f8a8fb07fb9b3af05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens J
Publicado: (2011) -
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012) -
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal C, et al.
Publicado: (2013) -
Quetiapine monotherapy for bipolar depression
por: Michael E Thase
Publicado: (2008) -
Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
por: Zhang L, et al.
Publicado: (2013)